SLNOW
Soleno Therapeutics Inc
Halal Rating :
Last Price
$0.02
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Soleno Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for rare diseases. Their lead candidate, DCCR (Diazoxide Choline), is being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disorder that causes life-threatening obesity.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Soleno Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.